Palbociclib (monohydrochloride) (Standard)
Palbociclib (monohydrochloride) (Standard) is the analytical standard of Palbociclib (monohydrochloride) . This product is intended for research and analytical applications. Palbociclib (PD 0332991) monohydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib monohydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma[1][3][4].
Product Specifications
CAS Number
827022-32-2
UNSPSC
12352100
Hazard Statement
H341, H361, H373, H411
Target
CDK; Reference Standards
Related Pathways
Cell Cycle/DNA Damage; Others
Field of Research
Cancer
Purity
99.95
Smiles
O=C1C(C(C)=O)=C(C)C2=CN=C(NC3=NC=C(N4CCNCC4)C=C3)N=C2N1C5CCCC5.Cl
Molecular Formula
C24H30ClN7O2
Molecular Weight
483.99
Precautions
H341, H361, H373, H411
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
4°C, sealed storage, away from light and moisture
Scientific Category
Reference Standards
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CTIP2 (BCL11B) (NM_001282238) Human Tagged ORF Clone
ARF1 (Golgi Apparatus Marker) (1A9/5), CF647 conjugate, 0.1mg/mL
